BOSTON, March 26, 2014 /PRNewswire/ — CBI is pleased to announce that Pharmaceutical Executive will reveal its prestigious Brand of the Year Award during iPharma 2014 – industry's leading marketing innovation summit – taking place May 8-9, 2014 in New York, NY. iPharma 2014 is the most compelling and comprehensive life sciences meeting, uniting key stakeholders in the world of digital marketing, strategy, branding, innovation, media, and IT to share the latest trends and real-world approaches to developing effective and innovative promotional campaigns. Executives from Arbor Pharmaceuticals, Auxilium, Bayer, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, CSL Behring, EMD Serono, GE Healthcare, Inspirion, Lilly, Lundbeck, Merck, Novartis, Ova Science, Pfizer, Purdue, Roche, Shire, UCB, Voltarra Pharmaceuticals and many other leading organizations round out the highly anticipated agenda.
Pharmaceutical Executive's annual Brand of the Year selection, to be announced during a special award ceremony at the conference, reflects the difficult decisions made by scientific and commercial teams, spanning the entire organization. In addition to the performance of the brand at launch and successful quarterly figures, the cumulative decisions made that power a brand's long-term trajectory – across multiple divisions, managers and geographic areas – such as access issues, lifecycle management and meaningful customer engagement will be key considerations.
Brand of the Year has been an annual feature in Pharmaceutical Executive magazine since 2008, when Pfizer's Chantix, a smoking cessation drug, won the inaugural designation. Since then, some of the largest brands on the market have been selected and profiled, including Genentech's Avastin (2010) and AbbVie's Humira (2012).
This year, a second Brand of the Year Award will be added for a rare disease medicine, in response to industry's increasing interest in this critical area of unmet need. Both Brand of the Year selections will be judged against the competition in the market, performance to date and the brand team's ability to engage successfully with patients, physicians, payers and regulators to affect the entire ecosystem of care, from drug delivery to health outcomes.
For more information or to download the complete conference agenda, visit www.cbinet.com/ipharma.
About CBI:
CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought-leaders and regulators. For more information, please visit www.cbinet.com or contact Emily Forest, Senior Marketing Manager, at 339-298-2156 or Email.
About Pharmaceutical Executive:
Pharmaceutical Executive probes the interface of business practice and public policy for the global biopharmaceutical, vaccine and medical device industries. PharmExec's editorial remit covers strategy in the "c-suite," as well as regulatory and legal actions; sales promotion and marketing; R&D; finance; HR; pricing and market access; and new technology. Published by Advanstar, PharmExec's editorial content is available in the award-winning monthly print edition, as well as in a number of digital platforms. For more information, please visit www.pharmexec.com or contact Bill Looney, Editor in Chief, at 212-951-6735 or Email.